nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP19A1—esophageal cancer	0.77	1	CbGaD
Etomidate—SLC2A1—neck—esophageal cancer	0.00379	0.247	CbGeAlD
Etomidate—SLC2A1—epithelium—esophageal cancer	0.00258	0.168	CbGeAlD
Etomidate—SLC2A1—trachea—esophageal cancer	0.00228	0.149	CbGeAlD
Etomidate—SLC2A1—digestive system—esophageal cancer	0.00196	0.128	CbGeAlD
Etomidate—SLC2A1—lung—esophageal cancer	0.00164	0.107	CbGeAlD
Etomidate—SLC2A1—lymph node—esophageal cancer	0.00112	0.0731	CbGeAlD
Etomidate—CYP11B2—lymph node—esophageal cancer	0.00096	0.0626	CbGeAlD
Etomidate—Fenoprofen—PTGS1—esophageal cancer	0.000662	0.636	CrCbGaD
Etomidate—GABRB2—lung—esophageal cancer	0.00064	0.0417	CbGeAlD
Etomidate—Fenoprofen—PTGS2—esophageal cancer	0.000379	0.364	CrCbGaD
Etomidate—CYP19A1—lymph node—esophageal cancer	0.000355	0.0231	CbGeAlD
Etomidate—ADRA2B—G alpha (i) signalling events—SST—esophageal cancer	0.000138	0.000645	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ENO1—esophageal cancer	0.000138	0.000644	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS1—esophageal cancer	0.000138	0.000644	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000137	0.000643	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000137	0.000643	CbGpPWpGaD
Etomidate—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000136	0.000635	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PSME2—esophageal cancer	0.000136	0.000634	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PSME1—esophageal cancer	0.000136	0.000634	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000135	0.000631	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC10A2—esophageal cancer	0.000132	0.00062	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA1—esophageal cancer	0.000132	0.00062	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLCE1—esophageal cancer	0.000131	0.000611	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ADH7—esophageal cancer	0.000131	0.000611	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000129	0.000604	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000129	0.000602	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000123	0.000577	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000123	0.000577	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PFN1—esophageal cancer	0.000123	0.000574	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFBR2—esophageal cancer	0.000121	0.000569	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000121	0.000567	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA2—esophageal cancer	0.000121	0.000567	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00012	0.000562	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000118	0.000554	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1B1—esophageal cancer	0.000117	0.000547	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000117	0.000547	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SMAD4—esophageal cancer	0.000115	0.000538	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ADH1B—esophageal cancer	0.000115	0.000536	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000114	0.000533	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000113	0.000527	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLCE1—esophageal cancer	0.000113	0.000527	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ADH7—esophageal cancer	0.000113	0.000527	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000111	0.000521	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP19A1—esophageal cancer	0.00011	0.000515	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00011	0.000513	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TYMP—esophageal cancer	0.000109	0.000512	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000107	0.000502	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000107	0.0005	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000107	0.0005	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP26A1—esophageal cancer	0.000106	0.000498	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000106	0.000497	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000106	0.000496	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000106	0.000494	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GNG7—esophageal cancer	0.000105	0.00049	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALOX15—esophageal cancer	0.000104	0.000486	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HMOX1—esophageal cancer	0.0001	0.00047	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CFL1—esophageal cancer	9.94e-05	0.000465	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.93e-05	0.000465	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TPI1—esophageal cancer	9.9e-05	0.000463	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTO1—esophageal cancer	9.9e-05	0.000463	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ADH1B—esophageal cancer	9.87e-05	0.000462	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	9.82e-05	0.000459	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.7e-05	0.000454	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCB1—esophageal cancer	9.63e-05	0.000451	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADCYAP1—esophageal cancer	9.59e-05	0.000449	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALDOB—esophageal cancer	9.49e-05	0.000444	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TYMP—esophageal cancer	9.43e-05	0.000441	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HIF1A—esophageal cancer	9.41e-05	0.00044	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GNG7—esophageal cancer	9.37e-05	0.000438	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.35e-05	0.000437	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL2—esophageal cancer	9.23e-05	0.000432	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	9.2e-05	0.00043	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP26A1—esophageal cancer	9.18e-05	0.000429	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GAPDH—esophageal cancer	9.14e-05	0.000428	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CRABP1—esophageal cancer	9.05e-05	0.000424	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALOX15—esophageal cancer	8.94e-05	0.000419	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC52A3—esophageal cancer	8.82e-05	0.000413	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BLVRB—esophageal cancer	8.82e-05	0.000413	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GDI2—esophageal cancer	8.79e-05	0.000411	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GNG7—esophageal cancer	8.61e-05	0.000403	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ANXA1—esophageal cancer	8.58e-05	0.000401	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS2—esophageal cancer	8.56e-05	0.000401	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTO1—esophageal cancer	8.53e-05	0.000399	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TPI1—esophageal cancer	8.53e-05	0.000399	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.48e-05	0.000397	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOTCH1—esophageal cancer	8.48e-05	0.000397	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SST—esophageal cancer	8.35e-05	0.000391	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALDOB—esophageal cancer	8.18e-05	0.000383	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GHRL—esophageal cancer	8.13e-05	0.000381	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALDH2—esophageal cancer	8.07e-05	0.000378	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	7.89e-05	0.000369	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.89e-05	0.000369	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GAPDH—esophageal cancer	7.87e-05	0.000368	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CRABP1—esophageal cancer	7.8e-05	0.000365	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CREBBP—esophageal cancer	7.69e-05	0.00036	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—esophageal cancer	7.68e-05	0.000359	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HSPA5—esophageal cancer	7.64e-05	0.000357	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2A6—esophageal cancer	7.59e-05	0.000355	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.56e-05	0.000354	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA1—esophageal cancer	7.5e-05	0.000351	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC10A2—esophageal cancer	7.5e-05	0.000351	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNG7—esophageal cancer	7.42e-05	0.000347	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	7.27e-05	0.00034	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS1—esophageal cancer	7.19e-05	0.000337	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ENO1—esophageal cancer	7.19e-05	0.000337	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PSME2—esophageal cancer	7.09e-05	0.000332	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PSME1—esophageal cancer	7.09e-05	0.000332	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALDH2—esophageal cancer	6.95e-05	0.000325	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—esophageal cancer	6.88e-05	0.000322	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA2—esophageal cancer	6.86e-05	0.000321	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKAP13—esophageal cancer	6.8e-05	0.000318	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.71e-05	0.000314	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	6.69e-05	0.000313	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—esophageal cancer	6.62e-05	0.00031	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2A6—esophageal cancer	6.54e-05	0.000306	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.51e-05	0.000305	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.46e-05	0.000302	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CREBBP—esophageal cancer	6.44e-05	0.000301	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—esophageal cancer	6.44e-05	0.000301	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADH7—esophageal cancer	6.38e-05	0.000299	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLCE1—esophageal cancer	6.38e-05	0.000299	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KMT2D—esophageal cancer	6.35e-05	0.000297	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.33e-05	0.000296	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—esophageal cancer	6.29e-05	0.000295	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE4D—esophageal cancer	6.22e-05	0.000291	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.2e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS1—esophageal cancer	6.2e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO1—esophageal cancer	6.2e-05	0.00029	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.19e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.19e-05	0.00029	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKAP13—esophageal cancer	6.18e-05	0.000289	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1B1—esophageal cancer	6.12e-05	0.000286	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PSME1—esophageal cancer	6.11e-05	0.000286	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PSME2—esophageal cancer	6.11e-05	0.000286	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNG7—esophageal cancer	5.92e-05	0.000277	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.91e-05	0.000277	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—esophageal cancer	5.76e-05	0.00027	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP19A1—esophageal cancer	5.75e-05	0.000269	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.67e-05	0.000266	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADCYAP1—esophageal cancer	5.66e-05	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ABL1—esophageal cancer	5.66e-05	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE4D—esophageal cancer	5.65e-05	0.000264	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADH1B—esophageal cancer	5.59e-05	0.000262	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1A—esophageal cancer	5.5e-05	0.000257	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNG7—esophageal cancer	5.38e-05	0.000252	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMP—esophageal cancer	5.35e-05	0.00025	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.33e-05	0.00025	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—esophageal cancer	5.27e-05	0.000247	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1B1—esophageal cancer	5.27e-05	0.000247	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMOX1—esophageal cancer	5.25e-05	0.000246	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—esophageal cancer	5.23e-05	0.000245	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL2—esophageal cancer	5.21e-05	0.000244	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP26A1—esophageal cancer	5.2e-05	0.000243	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.2e-05	0.000243	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—WWOX—esophageal cancer	5.18e-05	0.000242	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.17e-05	0.000242	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.15e-05	0.000241	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALOX15—esophageal cancer	5.07e-05	0.000237	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—esophageal cancer	5.04e-05	0.000236	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.96e-05	0.000232	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP19A1—esophageal cancer	4.96e-05	0.000232	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FKBP1A—esophageal cancer	4.93e-05	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ANXA1—esophageal cancer	4.85e-05	0.000227	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTO1—esophageal cancer	4.83e-05	0.000226	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPI1—esophageal cancer	4.83e-05	0.000226	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—WIF1—esophageal cancer	4.82e-05	0.000225	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL2—esophageal cancer	4.74e-05	0.000222	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SST—esophageal cancer	4.72e-05	0.000221	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALDOB—esophageal cancer	4.64e-05	0.000217	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GHRL—esophageal cancer	4.6e-05	0.000215	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—esophageal cancer	4.56e-05	0.000213	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMOX1—esophageal cancer	4.52e-05	0.000212	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GAPDH—esophageal cancer	4.46e-05	0.000209	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—esophageal cancer	4.46e-05	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CSNK1A1—esophageal cancer	4.44e-05	0.000208	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.44e-05	0.000208	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CRABP1—esophageal cancer	4.42e-05	0.000207	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ANXA1—esophageal cancer	4.4e-05	0.000206	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—esophageal cancer	4.38e-05	0.000205	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—esophageal cancer	4.34e-05	0.000203	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SST—esophageal cancer	4.28e-05	0.0002	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNG7—esophageal cancer	4.21e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GHRL—esophageal cancer	4.17e-05	0.000195	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PFN1—esophageal cancer	4.16e-05	0.000195	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.15e-05	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—esophageal cancer	4.08e-05	0.000191	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALDH2—esophageal cancer	3.94e-05	0.000184	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—esophageal cancer	3.87e-05	0.000181	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.81e-05	0.000178	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.79e-05	0.000177	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—esophageal cancer	3.75e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ELMO1—esophageal cancer	3.73e-05	0.000175	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2A6—esophageal cancer	3.71e-05	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.69e-05	0.000173	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CREBBP—esophageal cancer	3.66e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKAP13—esophageal cancer	3.65e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	3.58e-05	0.000167	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO1—esophageal cancer	3.51e-05	0.000164	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS1—esophageal cancer	3.51e-05	0.000164	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PSME1—esophageal cancer	3.46e-05	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PSME2—esophageal cancer	3.46e-05	0.000162	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	3.37e-05	0.000158	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CREBBP—esophageal cancer	3.37e-05	0.000158	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	3.34e-05	0.000156	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.31e-05	0.000155	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.28e-05	0.000154	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—esophageal cancer	3.28e-05	0.000153	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—esophageal cancer	3.24e-05	0.000152	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	3.18e-05	0.000149	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.02e-05	0.000141	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—esophageal cancer	3.01e-05	0.000141	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1B1—esophageal cancer	2.99e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	2.98e-05	0.000139	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CREBBP—esophageal cancer	2.9e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	2.81e-05	0.000132	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	2.8e-05	0.000131	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—esophageal cancer	2.76e-05	0.000129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	2.61e-05	0.000122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	2.61e-05	0.000122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	2.6e-05	0.000122	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—esophageal cancer	2.6e-05	0.000122	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.56e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SST—esophageal cancer	2.53e-05	0.000118	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.51e-05	0.000118	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—esophageal cancer	2.49e-05	0.000117	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	2.47e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	2.47e-05	0.000115	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.46e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	2.43e-05	0.000114	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—esophageal cancer	2.38e-05	0.000111	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—esophageal cancer	2.29e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	2.21e-05	0.000103	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—esophageal cancer	1.98e-05	9.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	1.96e-05	9.18e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.86e-05	8.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	1.86e-05	8.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	1.84e-05	8.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—esophageal cancer	1.78e-05	8.35e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—esophageal cancer	1.7e-05	7.94e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.64e-05	7.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	1.52e-05	7.11e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—esophageal cancer	1.47e-05	6.89e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—esophageal cancer	1.46e-05	6.84e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—esophageal cancer	1.45e-05	6.8e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	1.37e-05	6.41e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.35e-05	6.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	1.24e-05	5.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	1.22e-05	5.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.17e-05	5.45e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—esophageal cancer	1.12e-05	5.24e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	1.11e-05	5.2e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	1.06e-05	4.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	1.04e-05	4.86e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	9.18e-06	4.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	8.88e-06	4.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—esophageal cancer	8.45e-06	3.96e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—esophageal cancer	8.28e-06	3.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—esophageal cancer	7.37e-06	3.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	7.2e-06	3.37e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	6.25e-06	2.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—esophageal cancer	6.05e-06	2.83e-05	CbGpPWpGaD
